Ignite Creation Date:
2024-05-06 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05728008
Status:
COMPLETED
Last Update Posted:
2023-02-14
First Post:
2023-01-30
Brief Title:
Retrospective Observational Comparison Study Between Ustekinumab and Tofacitinib as Third Line Therapy in a Multicenter Cohort of Patients With Refractory Ulcerative Colitis
Sponsor:
IRCCS San Raffaele
Organization:
IRCCS San Raffaele
Organization Data
Organization:
IRCCS San Raffaele
Class:
OTHER
Study ID:
UST-TOFA3
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
IRCCS San Raffaele
Lead Sponsor Class:
OTHER
Responsible Party:
Mariangela Allocca
Responsible Party Title:
Gastroenterologist
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
IRCCS San Raffaele
Old Name:
None
Old Organization:
None